← Leaderboards
Sean C Murphy
University Of Washington
$14,363,365
Attributed
$17,883,115
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.8M · FY2009–25$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,383,893 · 11
FDA$499,222 · 2
By mechanism
U01$8,717,913 · 4
R01$3,936,217 · 1
R42$2,925,300 · 1
R21$895,523 · 2
K08$632,950 · 1
R41$596,975 · 1
Top collaborators
- Brandon Keith Wilder4 shared
- Nhi Khuong3 shared
Most similar at University Of Washington
Same institution · by research overlap
- Albert R La Spada$44,944,106
- Peter S Rabinovitch$49,936,459
- Warren C. Ladiges$25,544,366
- Karin E. Bornfeldt$36,322,585
- Alan Chait$20,398,633
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaParasitesMalaria VaccinesSporozoitesPlasmodiumVaccinesVaccinationLaboratoriesErythrocytesInfectionAttenuatedImmunogenicityT-LymphocyteCellsLiverUniversitiesAntigensWashingtonNonhuman PrimatePlasmodium FalciparumVaccine DevelopmentImmunityCircumsporozoite ProteinDesign
Grant awards (37)
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2025 · AI
Development of an oral liver-targeted prime-and-trap malaria vaccine$793,041
U01 · FY2025 · AI · contact PI
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2024 · AI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.$925,300
R42 · FY2024 · AI
Development of an oral liver-targeted prime-and-trap malaria vaccine$829,705
U01 · FY2024 · AI · contact PI
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2023 · AI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.$1,000,000
R42 · FY2023 · AI
Development of an oral liver-targeted prime-and-trap malaria vaccine$835,002
U01 · FY2023 · AI · contact PI
Liver resident memory for malaria$595,716
R01 · FY2023 · AI · contact PI
DDT-BMQ-0000100 Qualification of the Plasmodium falciparum 18S rRNA biomarker for malaria-endemic controlled human malaria infection studies$249,222
U01 · FY2023 · FD · contact PI
Liver resident memory for malaria$58,964
R01 · FY2023 · AI · contact PI
Integrating human and non-human primate data to understand the acquisition of pre-erythrocytic immunity in the face of previous malaria exposure$1,028,550
U01 · FY2022 · AI
Development of an oral liver-targeted prime-and-trap malaria vaccine$844,865
U01 · FY2022 · AI · contact PI
Liver resident memory for malaria$801,401
R01 · FY2022 · AI · contact PI
DDT-BMQ-0000107 Qualification of the Plasmodium falciparum 18S rRNA biomarker for malaria field studies$250,000
U01 · FY2022 · FD · contact PI
Liver resident memory for malaria$86,682
R01 · FY2022 · AI · contact PI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.$1,000,000
R42 · FY2021 · AI
Development of an oral liver-targeted prime-and-trap malaria vaccine$801,878
U01 · FY2021 · AI · contact PI
Liver resident memory for malaria$797,863
R01 · FY2021 · AI · contact PI
Establishing the Feasibility of using daily Dried Blood Spots (DBS) to study the Natural History of Low-density Asymptomatic Malaria Infection to Inform Malaria Elimination$185,313
R21 · FY2021 · AI · contact PI
Liver resident memory for malaria$27,718
R01 · FY2021 · AI · contact PI
Liver resident memory for malaria$819,482
R01 · FY2020 · AI · contact PI
Establishing the Feasibility of using daily Dried Blood Spots (DBS) to study the Natural History of Low-density Asymptomatic Malaria Infection to Inform Malaria Elimination$224,897
R21 · FY2020 · AI · contact PI
Liver-stage Plasmodium protein export to the host cell to inform vaccine design.$220,625
R21 · FY2020 · AI · contact PI
A Pilot Study to Evaluate Plasmodium falciparum Liver-Stage Challenge in Prime-and-Trap Vaccinated Rhesus Monkeys$88,250
R03 · FY2020 · AI · contact PI
Liver resident memory for malaria$748,391
R01 · FY2019 · AI · contact PI
Development of a Spirulina-based oral malaria vaccine$297,071
R41 · FY2019 · AI · contact PI
Liver-stage Plasmodium protein export to the host cell to inform vaccine design.$264,688
R21 · FY2019 · AI · contact PI
A Pilot Study to Evaluate Plasmodium falciparum Liver-Stage Challenge in Prime-and-Trap Vaccinated Rhesus Monkeys$88,125
R03 · FY2019 · AI · contact PI
Development of a Spirulina-based oral malaria vaccine$299,904
R41 · FY2018 · AI · contact PI
Identification of responding CD8+ T cells and novel protective epitopes following$126,864
K08 · FY2015 · AI · contact PI
Identification of responding CD8+ T cells and novel protective epitopes following$126,864
K08 · FY2014 · AI · contact PI
Identification of responding CD8+ T cells and novel protective epitopes following$126,864
K08 · FY2013 · AI · contact PI
Identification of responding CD8+ T cells and novel protective epitopes following$126,864
K08 · FY2012 · AI · contact PI
Identification of responding CD8+ T cells and novel protective epitopes following$125,494
K08 · FY2011 · AI · contact PI
GENOME ANNOTATION PIPELINE PROTOTYPE DEVELOPMENT$1,091
P41 · FY2010 · RR · contact PI
GENOME ANNOTATION PIPELINE PROTOTYPE DEVELOPMENT$771
P41 · FY2009 · RR · contact PI